Filing Details
- Accession Number:
- 0001209191-21-069092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-10 17:04:17
- Reporting Period:
- 2021-12-09
- Accepted Time:
- 2021-12-10 17:04:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1044378 | Biocept Inc | BIOC | Pharmaceutical Preparations (2834) | CA |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1024004 | F David Hale | C/O Biocept, Inc. 9955 Mesa Rim Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-09 | 363 | $4.06 | 3,114 | No | 4 | S | Indirect | By LLC |
Common Stock | Disposition | 2021-12-09 | 11 | $4.07 | 101 | No | 4 | S | Indirect | By trust |
Common Stock | Disposition | 2021-12-09 | 71 | $4.07 | 796 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By LLC |
No | 4 | S | Indirect | By trust |
No | 4 | S | Direct |
Footnotes
- The sales reported herein were made for tax planning purposes.